Joined February 2017
Thanks to all the presenters & attendees who took part in the 3rd virtual #CVCcolloquium on operationalizing #clinicalresearch. The session sparked some great questions & discussion! @tctcml @ShaunGoodman @ShelleyZieroth
1
2
6
The infamous #CVCcolloquium continues via Zoom ! HF trials during the pandemic ⁦@CVC_UAlberta⁩ ⁦@tctcml⁩
2
9
Excellent presentation from keynote speaker @Drroxmehran, who discussed mentoring and diversity in #clinicalresearch at the #CVCcolloquium.
1
1
6
Thanks to the attendees, keynote speaker, and facilitators for taking part in the 2nd virtual #CVCcolloquium on mentoring & diversity in #clinicalresearch. The session sparked some great discussion!  @Drroxmehran @ShelleyZieroth @shuangboliu @AlexBastiany @tctcml @ShaunGoodman
1
2
4
Thanks to the attendees, keynote speaker, and facilitators for taking part in the first virtual #CVCcolloquium on clinical research during a pandemic. A great opportunity to collaborate and exchange ideas! @texhern @ShelleyZieroth @tctcml @JustinEzekowitz @ShaunGoodman
1
6
Attendees + facilitators at the #CVCcolloquium participated in breakout sessions, discussing challenges facing clinical research during the pandemic, and pragmatic approaches for supporting clinical trials in the future. @ShelleyZieroth @tctcml @JustinEzekowitz @ShaunGoodman
1
1
5
Collaboration is the secret sauce of success in clinical trials. The ingredients have evolved over the years, but when trust and respect exists between the teams stirring the sauce, it creates a synergy that inspires us to aim higher to find new solutions to help our patients.
#25YearsOfVision | Hear from former DCRI director @HeartBobH & other DCRI-ers past & present about how DCRI generates evidence to improve health. WATCH: bit.ly/3kJJu6f @DanMarkMD @cbgranger @schuyler_jones @jinxrumor @Ty_Rorick @PedsDanny @DeraadRoger @VanceFowler5
1
3
Keynote speaker @texhern discusses clinical trials during a pandemic and what we've learned and where we're headed at the #CVCcolloquium. @ShelleyZieroth @tctcml @JustinEzekowitz @ShaunGoodman
1
2
6
Congratulations to CVC co-director @Padma_Kaul on her appointment as the Heart & Stroke Chair in Cardiovascular Research! @HeartandStroke
Please join us in congratulating Dr. Padma Kaul from our Division of Cardiology for her appointment as the Heart & Stroke Chair in Cardiovascular Research! Dr. Kaul will be responsible for being a leader in the development of cardiovascular research at the University of Alberta.
1
2
1
21
Clinical trials are made possible through the volunteer spirit and participation of patients. In this @BeTheCureAB research story, Deborah McLeod shares her experience as a participant in the #VICTORIAtrial. #vericiguat #healthresearch #UAlberta bethecure.ca/stories/deborah…
1
2
3
Presenting new findings from the #VICTORIAtrial, Dr. Robert Mentz (@robmentz) examined what can be learned about the important group of patients who have recurrent events after initial hospitalization for worsening #HF. #vericiguat #HFSA2020
2
10
Presenting insights from the #VICTORIAtrial, Dr. Justin Ezekowitz (@JustinEzekowitz) explored how to best define an optimal standard of background medical care. #vericiguat #HFSA2020
4
12
In his presentation from the #VICTORIAtrial session, Dr. Javed Butler (@JavedButler1) discussed where #vericiguat fits in the contemporary standard of care management of #HF. #HFSA2020
4
11
Presenting new insights from the #VICTORIAtrial, Dr. Adrian Hernandez (@texhern) highlighted how prognostic modelling in patients with #HFrEF and recent decompensation can help us understand the likelihood of unfavorable outcomes. #vericiguat #HFSA2020
4
12
Tune in Sunday Oct 4th at 10 AM EDT for a #HFSA2020 session on new data and learnings from the #VICTORIAtrial. Additional info here: bit.ly/3cVovJW @HFSA @DCRINews @JustinEzekowitz @robmentz @texhern @JavedButler1 @coconnormd
5
9
#Vericiguat beats placebo in the #VICTORIAtrial and shows a 33% reduction in primary endpoint (CVD/HFH) if NT-proBNP < 4000 pg/ml and 15% reduction if NT-proBNP <8000 pg/ml. #HFAdiscoveries
Tracy Temple retweeted
Paul W. Armstrong, MD, #VICTORIA trial PI, summarizes the results of the trial presented virtually at #ACC20. Hear his opinions about implications of findings on the use of vericiguat in patients with HFrEF. Watch: youtu.be/QpGqw0Z13-M
5
6
.@lamcardio discusses the results of the VICTORIA trial and the potential to reduce CV death & rehospitalization in patients with severe chronic heart failure and reduced ejection fraction with #Vericiguat: tv.clinicaltrialresults.org/…
1
13
1
33
#VICTORIA trial showing great promise of #Vericiguat for higher risk heart failure pts. ♦️4.2% absolute primary event reduction (per 100 pt-yrs when used with GDMT) ♦️NNT 24 @ACCinTouch @DCRINews
7
17
Tracy Temple retweeted
Merck and Bayer's heart drug vericiguat meets primary efficacy endpoint in Phase 3 study reuters.com/article/us-merck…
1
9
27